Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors.
The μ-opioid peptide (MOP) receptor is a member of the opioid receptor family and an important clinical target for analgesia. Measuring MOP receptor location and tracking its turnover traditionally used radiolabels or antibodies with attendant problems of utility of radiolabels in whole cells and po...
Main Authors: | Despina Giakomidi, Mark F Bird, John McDonald, Erika Marzola, Remo Guerrini, Serena Chanoch, Nidhuna Sabu, Barbara Horley, Girolamo Calo, David G Lambert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0250011 |
Similar Items
-
Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).
by: Mark F Bird, et al.
Published: (2016-01-01) -
INVESTIGATION OF INTERACTIONS BETWEEN DERMORPHIN ANALOGS AND µ-OPIOID RECEPTOR
by: AGNIESZKA KARCZYŃSKA, et al.
Published: (2014-10-01) -
Atto488-Agitoxin 2—A Fluorescent Ligand with Increased Selectivity for Kv1.3 Channel Binding Site
by: Kristina R. Denisova, et al.
Published: (2022-07-01) -
Rediscovery of old drugs: the forgotten case of dermorphin for postoperative pain and palliation
by: Keppel Hesselink JM, et al.
Published: (2018-11-01) -
Combining mKate2-Kv1.3 Channel and Atto488-Hongotoxin for the Studies of Peptide Pore Blockers on Living Eukaryotic Cells
by: Nikita A. Orlov, et al.
Published: (2022-12-01)